鲁抗医药：向特定对象发行股票获证监会同意注册批复

Core Points - The company has received approval from the China Securities Regulatory Commission for the registration of a stock issuance to specific investors [1] - The approval requires the company to implement the stock issuance plan within 12 months according to the submitted documents to the Shanghai Stock Exchange [1] - The company must report any significant events to the Shanghai Stock Exchange before the completion of the issuance and handle them according to relevant regulations [1] - The company's board of directors will manage the related matters within the stipulated timeframe and fulfill information disclosure obligations [1]